21924-83-4

Usage

Uses

Used in Pharmaceutical Industry:
4-(bromomethyl)-3-chlorobenzonitrile is used as a key intermediate for the synthesis of various drugs. Its unique structure allows it to be a building block in the development of new pharmaceutical compounds, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 4-(bromomethyl)-3-chlorobenzonitrile serves as an essential intermediate in the production of agrochemicals. Its role in creating effective and innovative agrochemical products highlights its importance in agricultural research and development.
Used in Dye and Perfume Production:
4-(bromomethyl)-3-chlorobenzonitrile is utilized as a key building block in the creation of dyes and perfumes. Its unique properties and reactivity make it a crucial component in the formulation of a wide array of colorants and fragrances, enhancing the quality and variety of products in these industries.
Used in Chemical Industry for Product Creation:
4-(bromomethyl)-3-chlorobenzonitrile's unique structure and properties make it an important ingredient in the chemical industry for the creation of a wide range of products. Its versatility in forming derivatives and participating in various chemical reactions positions it as a valuable asset in the development of new and innovative chemical products.

Upstream product

• 21423-81-4 3-chloro-4-methylbenzonitrile 
• 34241-39-9 azobisisobutyronitrile 
• 185315-48-4 (4-bromo-2-chlorophenyl)methanol 
• 1261618-25-0 3-chloro-4-(hydroxymethyl)benzonitrile 

Downstream Products

• 80762-31-8 diethyl 2-(2-chloro-4-cyanobenzyl)malonate 
• 202521-96-8 N-(2-chloro-4-cyanobenzyl)phthalimide 
• 58588-64-0 3-chloro-4-formyl-benzonitrile 
• 914106-38-0 2-chloro-4-cyanobenzaldoxime 
• 914106-02-8 2-chloro-4-cyanobenzaldehyde chlorooxime 
• 914106-10-8 3-(2-chloro-4-cyanophenyl)-5-(4-cyanophenyl)isoxazole 
• 914106-18-6 3-(2-chloro-4-cyanophenyl)-5-(3-cyanophenyl)isoxazole 
• 182292-05-3 4-(aminomethyl)-3-chlorobenzonitrile hydrochloride 
• 549531-00-2 di-tert-butyl [2-chloro-4-cyanobenzylamino]dicarboxylate 
• 928137-17-1 3-Chloro-4-[5-(4-chlorobutyl)imidazol-1-ylmethyl]benzonitrile 
• 1416978-62-5 (E)-N-(2-Chloro-4-(4,4,4-trifluoro-3-(3,4,5-trichlorophenyl)but-1-en-1-yl)benzyl)pyridin-2-amine 
• 1416978-50-1 (E)-1-(2-Chloro-4-(3-(3,5-dichlorophenyl)-4,4,4-trifluorobut-1-en-1-yl)benzyl)-3-ethylurea 
• 1416978-26-1 (E)-N-(2-Chloro-4-(3-(3,5-dichlorophenyl)-4,4,4-trifluorobut-1-en-1-yl)benzyl)acetamide 

Relevant academic research and scientific papers

[6,6] FUSED BICYCLIC HDAC8 INHIBITORS

The present invention is directed to compounds of Formula I: and pharmaceutically acceptable salts, prodrugs, solvates, hydrates, tautomers, or isomers or thereof, wherein R1, R2, R2', L, X, W, Y1,Y2,

Pesticidal compositions and processes related thereto

This document discloses molecules having the following formula (“Formula One”): and processes associated therewith.

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

This document discloses molecules having the following formula ("Formula One"): and processes associated therewith.

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

This document discloses molecules having the following formula (“Formula One”): and processes associated therewith.

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

This document discloses molecules having the following formula ("Formula One") and processes associated therewith.

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

This document discloses molecules having the following formula (“Formula One”): and processes associated therewith.

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

This document discloses molecules having the following formula (“Formula One”): and processes associated therewith.

PAR2 RECEPTOR ANTAGONISTS

Compounds of formula (I) or pharmaceutically acceptable salts, solvates or hydrates thereof wherein P, Q, X, Y, R1, R2, R3, R10, R11, and R12 are as defined in the claims, and the use those compounds in medicine.

RECEPTOR ANTAGONISTS

N-(4-carbamimidoylphenyl)-amide derivatives having utility in therapy as PAR2 receptor antagonists.

An efficient synthesis of optically active trifluoromethyl aldimines via asymmetric biomimetic transamination

This communication describes a chiral base-catalyzed asymmetric [1,3]-proton shift of trifluoromethyl ketimines, giving a wide variety of trifluoromethyl aldimines containing various functional groups with up to 94% ee.